Skip to main content
. Author manuscript; available in PMC: 2021 Feb 10.
Published in final edited form as: J Proteomics. 2019 Nov 21;212:103595. doi: 10.1016/j.jprot.2019.103595

Table 2.

Affinity purification-mass spectrometry experimental parameters reported in Dickinson et al. and Olson et al. &

Dickinson et al.* Olson et al.&
Tissue type HeLa 229 cells HeLa 229 cells
Inc-APEX2 construct IncB-APEX2 IncF-APEX2, IncA-APEX2, IncATM-APEX2
Affinity Purification Streptavidin-agarose resin Streptavidin Magnetic beads
Elution On resin trypsin digestion SDS-PAGE and sectioned
Digestion Enzyme(s) Trypsin Trypsin and AspN
Mass Spectrometer Thermo Fisher Velos Orbitrap Thermo Fisher Orbitrap Lumos
Software MS-GF+ Release (v2016.10.24) Mascot and Scaffold
Protein modifications Carbamidomethyl and Oxidation Carbamidomethyl and Oxidation
Fasta search Homo sapiens UniProt SPROT accessed 20170412 UniProt Human accessed 20180927
Fasta search C. trachomatis C. trachomatis L2 434/Bu pL2 Plasmid accessed 20180105 C. trachomatis L2 434/Bu accessed 20180330
Peptide/protein Filtering False Discovery Rate ≤ 1%, Unique peptides, requiring a minimum of six amino acids in length, were filtered using an MS-GF threshold of ≤ 1×10−9, corresponding to an estimated false-discovery rate (FDR) <1% at a peptide level. Scaffold filtering: 95% protein threshold, 1-peptide minimum, 95% peptide threshold
Additional data processing Relative peptide abundances were log-transformed. Elimination of statistical outliers was confirmed using a standard Pearson correlation at a sample level
Statistical Test G-test and T-test SAINT#
*

previously published in Dickinson et al., PLoS Pathog. 2019 15(4):e1007698, doi: 10.1371/journal.ppat.1007698

&

previously published in Olson et al., Infection and Immunity. 2019

#

Significance Analysis of INTeractome (SAINT)